| EP4243878 - LIVER-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.08.2023 Database last updated on 14.03.2026 | |
| Former | The international publication has been made Status updated on 21.05.2022 | Most recent event Tooltip | 27.11.2025 | New entry: Renewal fee paid | Applicant(s) | For all designated states Surrozen Operating, Inc. 171 Oyster Point Blvd. Suite 400 South San Francisco, CA 94080 / US | [2023/38] | Inventor(s) | 01 /
LI, Yang Mountain View, California 94040 / US | 02 /
ZHANG, Zhengjian Albany, California 94706 / US | 03 /
BREZSKI, Randall J. Alameda, California 94501 / US | 04 /
PRESTA, Leonard San Francisco, California 941098 / US | 05 /
LOPEZ, Thomas Palo Alto, California 94305 / US | 06 /
CHEN, Hui Foster City, California 94404 / US | 07 /
BARIBAULT, Helene Redwood City, California 94062 / US | 08 /
YEH, Wen-Chen Belmont, California 94003 / US | 09 /
TU, Shengjiang Foster City, California 94404 / US | [2023/38] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [2023/38] | Application number, filing date | 21893034.5 | 16.11.2021 | [2023/38] | WO2021US59564 | Priority number, date | US202063114457P | 16.11.2020 Original published format: US 202063114457 P | US202163182106P | 30.04.2021 Original published format: US 202163182106 P | US202163248157P | 24.09.2021 Original published format: US 202163248157 P | [2023/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022104280 | Date: | 19.05.2022 | Language: | EN | [2022/20] | Type: | A1 Application with search report | No.: | EP4243878 | Date: | 20.09.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.05.2022 takes the place of the publication of the European patent application. | [2023/38] | Search report(s) | International search report - published on: | US | 19.05.2022 | (Supplementary) European search report - dispatched on: | EP | 15.04.2025 | Classification | IPC: | A61K47/68 | [2023/38] | CPC: |
C07K16/28 (EP);
C07K14/4705 (EP,KR,US);
A61P1/16 (KR,US);
C07K16/24 (US);
C07K16/2851 (EP,KR);
C12N15/62 (EP);
A61K2039/505 (EP,KR);
A61K38/00 (US);
C07K2317/24 (EP,KR,US);
C07K2317/52 (EP,KR);
C07K2317/55 (EP,KR);
C07K2317/56 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/38] | Title | German: | LEBERSPEZIFISCHE WNT-SIGNALVERSTÄRKENDE MOLEKÜLE UND VERWENDUNGEN DAVON | [2023/38] | English: | LIVER-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF | [2023/38] | French: | MOLÉCULES D'AMÉLIORATION DE SIGNAUX WNT SPÉCIFIQUES DU FOIS ET LEURS UTILISATIONS | [2023/38] | Entry into regional phase | 15.06.2023 | National basic fee paid | 15.06.2023 | Search fee paid | 15.06.2023 | Designation fee(s) paid | 15.06.2023 | Examination fee paid | Examination procedure | 15.06.2023 | Examination requested [2023/38] | 06.11.2025 | Amendment by applicant (claims and/or description) | 06.11.2025 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 24.11.2023 | Renewal fee patent year 03 | 26.11.2024 | Renewal fee patent year 04 | 26.11.2025 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I] WO2020014271 (SURROZEN INC et al.) [I] 1-3,5-14 * paragraphs [0007] - [0032] - [0082] - [0086] - [0097] , [0249]; sequence 30 * | [XI] WO2018140821 (SURROZEN INC et al.) [X] 13,14 * paragraphs [0007] - [0029] - [0036] - [0049] - [0091] , [0092] , [0215] - [0222] *[I] 1-3,5-12 | International search | [X] US2020048324 (ZHANG ZHENGJIAN et al.) [X] 1-4, 39-42 * claim 5, para [0008], [0011], [0013], [0084], [0105], [0117], [0147], [0245], SEQ ID NOs: 72, 86 * | [A] US2015299324 (HOFER THOMAS et al.) [A] 1-4,39-42 * abstract, para [0106], SEQ ID NO: 68 * | by applicant | WO2011130624 | WO2012138453 | WO2013052523 | WO2013151666 | WO2013071047 | WO2013078199 | WO2012045075 | WO2014081507 | WO2014093924 | WO2014164253 | US8278036 | US8691966 | US8835108 | US8748089 | KNIGHTHANKENSON, MATRIX BIOLOGY, vol. 37, 2014, pages 157 - 161 | ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 | ALTSCHUL ET AL., NUCLEIC ACIDS RES, vol. 25, 1997, pages 3389 - 3402 | TATUSOVAMADDEN, FEMS MICROBIOL LETT, vol. 174, 1999, pages 247 - 250 | "Methods in Enzymology", vol. 266, OXFORD MOLECULAR GROUP, INC., article "Genetics Computing Group (GCG" | BOLLAG ET AL.: "Computer Methods for Macromolecular Sequence Analysis", 1996, ACADEMIC PRESS, INC. | METH. MOL. BIOL., vol. 70, 1997, pages 173 - 187 | J. MOL. BIOL., vol. 48, 1970, pages 443 - 453 | SMITHWATERMAN, ADVANCES IN APPLIED MATHEMATICS, vol. 2, 1981, pages 482 - 489 | ALAN R: "Macromolecule Sequencing and Synthesis", 1988, LISS, INC., article "Current Methods in Sequence Comparison and Analysis", pages: 127 - 149 | SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 2001, HARBOR LABORATORY PRESS | "Oligonucleotide Synthesis", 1984 | "Gene Transfer Vectors for Mammalian Cells", 1987 | "Handbook of Experimental Immunology", 1994 | STOCKERTMORELLASHWELL, TARGETED DIAGNOSTICS AND THERAPY, vol. 4, 1991, pages 41 - 64 | YAN ET AL., TUMOR BIOLOGY, vol. 36, 2015, pages 55 - 67 | D'SOUZADEVARAJAN, JOURNAL OF CONTROLLED RELEASE, vol. 203, 2015, pages 126 - 139 | SCATCHARD ET AL., ANN. N. Y. ACAD. SCI., vol. 51, 1949, pages 660 | "Remington's Pharmaceutical Sciences", 1985, MARK PUBLISHING COMPANY | MCCOY AJGROSSE-KUNSTLEVE RWADAMS PDWINN MDSTORONI LCREAD RJ, J APPL CRYSTALLOGR, vol. 40, 2007, pages 658 - 674 | J. PHARM. SCI., vol. 66, no. 2, 1977 | STAHLWERMUTH: "Handbook of Pharmaceutical Salts: Properties, Selection, and Use", 2002, WILEY-VCH | BERGE ET AL.: "Pharmaceutical Salts", J. PHARMA SCI., vol. 66, 1977, pages 119 | GOOD ET AL., BIOCHEMISTRY, vol. 5, 1966, pages 467 | "Short Protocols in Molecular Biology", 1999, JOHN WILEY & SONS | "Viral Vectors", 1995, ACADEMIC PRESS | "Immunology Methods Manual", 1997, ACADEMIC PRESS | DOYLEGRIFFITHS: "Cell and Tissue Culture: Laboratory Procedures in Biotechnology", 1998, JOHN WILEY & SONS | JANDA ET AL., NATURE, vol. 545, 2017, pages 234 | SANHUEZA CABAKSH MMTHUMA BROY MDDUTTA SPREVILLE CCHRUNYK BABEAUMONT KDULLEA RAMMIRATI M, J. AM. CHEM. SOC., vol. 139, 2017, pages 3528 - 3536 | P.D. ADAMSP.V. AFONINEG. BUNKOCZIV.B. CHENI.W. DAVISN. ECHOLSJ.J. HEADDL.W. HUNGG.J. KAPRALR.W. GROSSE-KUNSTLEVE, ACTA CRYST, vol. D66, 2010, pages 486 - 501 | MEIER MBIDER MDMALSHKEVICH VNSPIESS MBURKHARD P, J MOL BIOL, vol. 300, 2012, pages 857 - 865 | SATO, Y.WATANABE, H.KAMEYAMA, H.KOBAYASHI, T.YAMAMOTO, S.TAKEISHI, T.HIRANO, K.OYA, H.NAKATSUKA, H.WATANABE, T.: "Journal Title: Transplantation Proceedings", vol. 36, October 2004, PUBLISHER: ELSEVIER. PUBLICATION, pages: 2359 - 2361 | SLOWIK, VBORUDE, PJAESCHKE, HWOOLBRIGHT, BLEE, WAPTE, U: "Journal Title: Translational Gastroenterology and Hepatology", vol. 4, March 2019, AME PUBLISHING COMPANY, article "Acute Liver Failure Study Group", pages: 2359 - 2361 |